Overview

Russian Study of the Efficacy and Safety of Tarka in Patients With Hypertension

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
This study will investigate antihypertensive activity and safety profile of Tarka in Russian hypertension patients by ambulatory blood pressure measurement (ABPM)
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Abbott
Treatments:
Trandolapril
Verapamil
Criteria
Inclusion Criteria:

- Hypertension

Exclusion Criteria:

- SBP > 180 mm Hg, DBP > 114 mm Hg

- Subject has a hypersensitivity to trandolapril or verapamil